alexa Panton-valentine Leukocidin Does Not Exist As A Coupled Molecule: LukS-PV Subunit Becomes Active Leukocytolytic Toxin Following Phosphorylative Activation By LukF-PV Subunit
ISSN: 2155-9597

Journal of Bacteriology & Parasitology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

2nd International Congress on Bacteriology & Infectious Diseases
November 17-19, 2014 DoubleTree by Hilton Hotel Chicago-North Shore, USA

Charles Okolie, Karl Wooldridge, David Turner, Alan Cockayne and Richard James
Accepted Abstracts: J Bacteriol Parasitol
DOI: 10.4172/2155-9597.S1.008
Panton-Valentine leukocidin (PVL) is one of the numerous toxins secreted by Staphylococcus aureus. It has long been established that the pro-toxin subunits of PVL (LukS-PV and LukF-PV, also called S and F subunits respectively) are inert to human leukocytes. Previous publications elsewhere showed the active (leukocytolytic) toxin was formed via coupling of S subunit to F subunit following sequential binding of S and F subunits on leukocyte surfaces. In the current study, combined evidences from bioinformatics, cell-based assays, mass spectrometry, isoelectric point (pI), native and denaturing protein gels reveal that: i) the active leukocytolytic toxin is induced by phosphorylative activation of S subunit by F subunit, ii) establishment of the leukocytolytic principle does not require the sequential binding on leukocyte surface by S subunit ahead of F subunit, and iii) no nascent molecule different from LukS-PV is formed. Dephosphorylation of LukF-PV subunit led to abrogation of PVLinduced leukocytolysis. This phenomenon is only possible in-vitro as phosphorylation underpins most physiological processes including digestion, respiration, and locomotion. To proffer therapeutic solution to this rapidly mortifying syndrome, we further show that monoclonal antibodies against LukF-PV subunit prevented PVL-induced leukocytolysis and could be used in-vivo against PVL-induced leukocytolysis.
Charles Okolie completed his PhD from the University of Nottingham. He is currently a faculty member at Landmark University, a private university in Omu-Aran, Kwara State, Nigeria. He is also the Principal Investigator of the Human Microbiome Project in Nigeria (HMP-Nigeria), a research partnership between Landmark University and the Nigerian Institute of Medical Research (NIMR), Yaba, Lagos State. He has published numerous papers in reputed journals and served as reviewer for several journals.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version